{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002418","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001371737","attributes":{"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"4 min; 30 sec ON/ 30 sec OFF\""],"CHIP_ANTIBODY":["H3K27ac"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["199"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor NGS (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"717M","NAME":"S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160309.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160309.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"d655ae7382150ec1cc4f636c3edfb740"},{"FORMAT":"bigBed","SIZE":"1.5M","NAME":"S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160527.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160527.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"af95ed39d52333752d6000d29e5749ce"},{"FORMAT":"BED","SIZE":"1.8M","NAME":"S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160527.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160527.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"8cbb68e1cfd3b29b80ed19a253e0dd42"},{"FORMAT":"Text","SIZE":"2.0M","NAME":"S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160527.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01RFW/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01RFWH1.ERX1347892.H3K27ac.bwa.GRCh38.20160527.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"356f9dbc0d96b007c39c2e8cd5f942af"}],"dataset_id":"EGAD00001002418","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"S01RFW","sample_barcode":"S01RFWH1","attributes":{"DONOR_HEALTH_STATUS":["Acute Myeloid Leukemia"],"DONOR_AGE":["0 - 18"],"MOLECULE":["genomic DNA"],"DISEASE":["Acute Myeloid Leukemia"],"BIOMATERIAL_PROVIDER":["Anke Bergmann"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"7","label":"C0023467"}],"SUBJECT_ID":["S01RFW"],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"UBERON_0013756"}],"GENDER":["unknown"],"DONOR_ID":["S01RFW"],"DONOR_SEX":["Unknown"],"SEX":["unknown"],"DONOR_ETHNICITY":["NA"]},"SAMPLE_ID":"EGAN00001360033","SAMPLE_DESCRIPTION":"Acute Myeloid Leukemia"}}